Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Franck Durif

Showing results (21-30 of 122) with videos related to

Pageof 13
Sort By:
The Journal of Headache and Pain|February 18, 2016
Nigrostriatal dopaminergic depletion increases static orofacial allodyniaWisam Dieb, Omar Ouachikh, Sofia Alves, et al.
Human Genetics|April 4, 2008
Gene symbol: PARK2. Disease: Parkinsonism, juvenile, autosomal recessiveSuzanne Lesage, Ebba Lohmann, François Tison, et al.
ISRN Neurology|March 6, 2012
Embodying Emotional Disorders: New Hypotheses about Possible Emotional Consequences of Motor Disorders in Parkinson's Disease and Tourette's SyndromeMartial Mermillod, Nicolas Vermeulen, Sylvie Droit-Volet, et al.
Neuroscience Letters|July 26, 2021
Nigrostriatal dopamine depletion promoted an increase in inhibitory markers (parvalbumin, GAD67, VGAT) and cold allodyniaMennatallah Elshennawy, Omar Ouachikh, Shereen Adel Saad, et al.
Plos One|March 8, 2013
Is R2* a new MRI biomarker for the progression of Parkinson's disease? A longitudinal follow-upMiguel Ulla, Jean Marie Bonny, Lemlih Ouchchane, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|September 17, 2004
Safety of entacapone and apomorphine coadministration in levodopa-treated Parkinson's disease patients: pharmacokinetic and pharmacodynamic results of a multicenter, double-blind, placebo-controlled, cross-over studyJan C M Zijlmans, Berengere Debilly, Olivier Rascol, et al.
Radiology|August 4, 2015
Proton MR Spectroscopy for Diagnosis and Evaluation of Treatment Efficacy in Parkinson DiseaseLeslie Mazuel, Carine Chassain, Betty Jean, et al.
Experimental Neurology|January 15, 2005
Cerebral glutamate metabolism in Parkinson's disease: an in vivo dynamic (13)C NMS study in the ratCarine Chassain, Guy Bielicki, Jean-Pierre Donnat, et al.
Parkinsonism & Related Disorders|August 3, 2020
Subcutaneous apomorphine infusion in advanced idiopathic Parkinson's disease and agranulocytosis: a case reportSakahlé Condé, Ana Marques, Philippe Derost, et al.
Annals of Neurology|May 30, 2020
Is Rapid Eye Movement Sleep Behavior Disorder a Risk Factor for Impulse Control Disorder in Parkinson Disease?Maria Livia Fantini, Janel Fedler, Bruno Pereira, et al.
Pageof 13

Showing results (21-30 of 122) with videos related to

Sort By:
Pageof 13
The Journal of Headache and Pain|February 18, 2016
Nigrostriatal dopaminergic depletion increases static orofacial allodyniaWisam Dieb, Omar Ouachikh, Sofia Alves, et al.
Human Genetics|April 4, 2008
Gene symbol: PARK2. Disease: Parkinsonism, juvenile, autosomal recessiveSuzanne Lesage, Ebba Lohmann, François Tison, et al.
ISRN Neurology|March 6, 2012
Embodying Emotional Disorders: New Hypotheses about Possible Emotional Consequences of Motor Disorders in Parkinson's Disease and Tourette's SyndromeMartial Mermillod, Nicolas Vermeulen, Sylvie Droit-Volet, et al.
Neuroscience Letters|July 26, 2021
Nigrostriatal dopamine depletion promoted an increase in inhibitory markers (parvalbumin, GAD67, VGAT) and cold allodyniaMennatallah Elshennawy, Omar Ouachikh, Shereen Adel Saad, et al.
Plos One|March 8, 2013
Is R2* a new MRI biomarker for the progression of Parkinson's disease? A longitudinal follow-upMiguel Ulla, Jean Marie Bonny, Lemlih Ouchchane, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|September 17, 2004
Safety of entacapone and apomorphine coadministration in levodopa-treated Parkinson's disease patients: pharmacokinetic and pharmacodynamic results of a multicenter, double-blind, placebo-controlled, cross-over studyJan C M Zijlmans, Berengere Debilly, Olivier Rascol, et al.
Radiology|August 4, 2015
Proton MR Spectroscopy for Diagnosis and Evaluation of Treatment Efficacy in Parkinson DiseaseLeslie Mazuel, Carine Chassain, Betty Jean, et al.
Experimental Neurology|January 15, 2005
Cerebral glutamate metabolism in Parkinson's disease: an in vivo dynamic (13)C NMS study in the ratCarine Chassain, Guy Bielicki, Jean-Pierre Donnat, et al.
Parkinsonism & Related Disorders|August 3, 2020
Subcutaneous apomorphine infusion in advanced idiopathic Parkinson's disease and agranulocytosis: a case reportSakahlé Condé, Ana Marques, Philippe Derost, et al.
Annals of Neurology|May 30, 2020
Is Rapid Eye Movement Sleep Behavior Disorder a Risk Factor for Impulse Control Disorder in Parkinson Disease?Maria Livia Fantini, Janel Fedler, Bruno Pereira, et al.
Pageof 13